Hepatocellular carcinoma (HCC) is a major global health challenge with rising incidence. Despite the previous approval of several novel therapeutic approaches, HCC remains the second common cause of cancer-related death worldwide. The vast majority of HCCs arises in the context of chronic fibrotic liver diseases caused by viral or metabolic etiologies. In patients with advanced liver disease the risk of HCC persists even after viral cure or control of infection. Moreover, given the change in the lifestyle and increase of obesity and metabolic disorders, HCC incidence is predicted to drastically augment in the next decade. Early detection, improvement of the screening method in patient at-risk and development of chemopreventive strategies ar...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated mortality globally. Given the...
The prognosis of patients with hepatocellular carcinoma is dependent on the stage of tumor at diagno...
Hepatocellular carcinoma (HCC), as the fifth most diagnosed cancer in the world and the third leadin...
Liver cancer remains a global health challenge, with an estimated incidence of >1 million cases b...
Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide and one of the deadliest. ...
Keywords: hepatocellular carcinoma; risk factors; molecular mechanisms; liquid biopsy; early diagnos...
Hepatocellular carcinoma (HCC) occurs almost exclusively in patients with chronic liver diseases (CL...
Over 1 million cases of liver cancer are estimated to occur by 2025, making it a global health chall...
Hepatocellular carcinoma (HCC) is responsible for significant morbidity and mortality throughout the...
The accuracy and the reliability of well-recognized clinical, virologic, histologic, and molecular r...
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. The major etiol...
Liver cirrhosis is an advanced stage of liver fibrosis causing liver failure, and may progress to he...
AbstractThe worldwide prevalence of hepatocellular carcinoma (HCC) is substantially increasing. Appr...
SummaryHepatocellular carcinoma (HCC) is a common cancer worldwide that primarily develops in cirrho...
Hepatocellular carcinoma (HCC) is the fourth leading global cause of tumor-related mortality. HCC ha...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated mortality globally. Given the...
The prognosis of patients with hepatocellular carcinoma is dependent on the stage of tumor at diagno...
Hepatocellular carcinoma (HCC), as the fifth most diagnosed cancer in the world and the third leadin...
Liver cancer remains a global health challenge, with an estimated incidence of >1 million cases b...
Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide and one of the deadliest. ...
Keywords: hepatocellular carcinoma; risk factors; molecular mechanisms; liquid biopsy; early diagnos...
Hepatocellular carcinoma (HCC) occurs almost exclusively in patients with chronic liver diseases (CL...
Over 1 million cases of liver cancer are estimated to occur by 2025, making it a global health chall...
Hepatocellular carcinoma (HCC) is responsible for significant morbidity and mortality throughout the...
The accuracy and the reliability of well-recognized clinical, virologic, histologic, and molecular r...
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. The major etiol...
Liver cirrhosis is an advanced stage of liver fibrosis causing liver failure, and may progress to he...
AbstractThe worldwide prevalence of hepatocellular carcinoma (HCC) is substantially increasing. Appr...
SummaryHepatocellular carcinoma (HCC) is a common cancer worldwide that primarily develops in cirrho...
Hepatocellular carcinoma (HCC) is the fourth leading global cause of tumor-related mortality. HCC ha...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated mortality globally. Given the...
The prognosis of patients with hepatocellular carcinoma is dependent on the stage of tumor at diagno...
Hepatocellular carcinoma (HCC), as the fifth most diagnosed cancer in the world and the third leadin...